Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02381314 |
| Title | Safety Study of MGA271 in Combination With Ipilimumab in Refractory Cancer |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | MacroGenics |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| UCLA Hematology-Oncology Clinic | Los Angeles | California | 90095 | United States | Details | |
| Yale University | New Haven | Connecticut | 06520 | United States | Details | |
| Mount Sinai Medical Center | Miami Beach | Florida | 33140 | United States | Details | |
| University of Chicago | Chicago | Illinois | 60637 | United States | Details | |
| Indiana University Simon Cancer Center | Indianapolis | Indiana | 46202 | United States | Details | |
| Washington University School of Medicine in St. Louis | Saint Louis | Missouri | 63110 | United States | Details | |
| Columbia University Medical Center | New York | New York | 10032 | United States | Details | |
| Providence Portland Medical Center | Portland | Oregon | 97213 | United States | Details | |
| Center for Oncology and Blood Disorders | Houston | Texas | 77030 | United States | Details | |
| University of Wisconsin | Madison | Wisconsin | 53792 | United States | Details |